New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
07:29 EDTATNM, ESPR, TGTX, ZIOP, KBIO, HZNP, EBIO, OMER, FPRX, RGDO, DRNABioCentury to hold a conference
Future Leaders in the Biotech Industry Conference is being held in New York on March 28.
News For ATNM;RGDO;FPRX;OMER;EBIO;HZNP;KBIO;ZIOP;TGTX;ESPR;DRNA From The Last 14 Days
Check below for free stories on ATNM;RGDO;FPRX;OMER;EBIO;HZNP;KBIO;ZIOP;TGTX;ESPR;DRNA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 13, 2014
10:01 EDTRGDOOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: CSR (CSRE) downgraded to Hold from Buy at Jefferies... Celadon Group (CGI) downgraded to Equal Weight from Overweight at Stephens... Cree (CREE) downgraded to Hold from Buy at Summit Research... Crestwood Equity (CEQP) downgraded to Underweight from Equal Weight at Barclays... Intrepid Potash (IPI) downgraded to Sell from Hold at BGC Financial... JDSU (JDSU) downgraded to Neutral from Buy at B. Riley... King Digital (KING) downgraded to Equal Weight from Overweight at Barclays... Marin Software (MRIN) downgraded to Neutral from Buy at Goldman... Mosaic (MOS) downgraded to Sell from Hold at BGC Financial... Potash (POT) downgraded to Sell from Hold at BGC Financial... Regado Biosciences (RGDO) downgraded to Market Perform from Outperform at Cowen... Southern Company (SO) downgraded to Underweight from Equal Weight at Morgan Stanley... StarTek (SRT) downgraded to Equal Weight from Overweight at First Analysis... Tuniu (TOUR) downgraded to Neutral from Outperform at Credit Suisse.
07:35 EDTEBIOEleven Biotherapeutics reports Q2 EPS (51c), two estimates (45c)
Subscribe for More Information
07:32 EDTHZNPHorizon Pharma, POZEN announce USPTO Notice of Allowance for VIMOVO
Subscribe for More Information
06:15 EDTRGDORegado Biosciences downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
August 12, 2014
08:06 EDTESPREsperion Therapeutics sees Phase 2b ETC-1002-008 trial results in October
Subscribe for More Information
06:56 EDTESPREsperion Therapeutics sees FY14 net cash operating activities $37M-$40M
Subscribe for More Information
06:56 EDTESPREsperion Therapeutics reports Q2 EPS (60c), consensus (60c)
Subscribe for More Information
August 11, 2014
16:42 EDTRGDORegado Biosciences reports Q2 EPS (63c), consensus (51c)
Cash and cash equivalents at June 30, totaled $72.7M compared to $30.7M at December 31, 2013.
16:15 EDTOMEROmeros reports Q2 EPS (53c) with items, consensus (52c)
Reports Q2 revenue $45,000, consensus $130,000. Q2 results included $2.5M, or 7c per share of non-cash expenses. The decrease in revenue, year over year, was due to a reduction of activity on NIH grant projects, which resulted in lower revenue being recognized.
August 8, 2014
10:34 EDTHZNPOptions with decreasing implied volatility
Subscribe for More Information
07:35 EDTHZNPHorizon announces S-4 registration statement for Vidara declared effective
Subscribe for More Information
August 7, 2014
17:13 EDTHZNPVisium reports 5.5% passive stake in Horizon Pharma
Subscribe for More Information
16:55 EDTZIOPZiopharm reports Q2 EPS (6c), consensus (13c)
Subscribe for More Information
10:20 EDTHZNPHigh option volume stocks
Subscribe for More Information
09:08 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
08:05 EDTKBIOKaloBios provides update on clinical programs
Subscribe for More Information
08:02 EDTKBIOKaloBios reports Q2 EPS (30c), consensus (34c)
Subscribe for More Information
06:46 EDTHZNPHorizon Pharma sees FY15 revenue $380M-$405M, consensus $351.77M
Subscribe for More Information
06:45 EDTHZNPHorizon Pharma backs FY14 revenue guidance of $270M-$280M, consensus $268.95M
Backs adjusted EBITDA guidance of $80M-$90M.
06:43 EDTHZNPHorizon Pharma reports Q2 adjusted EPS 21c, consensus 10c
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use